Evidence map›Paper›PMID 32248218›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2020

Hypericin photodynamic activity in DPPC liposomes - part II: stability and application in melanoma B16-F10 cancer cells.

Flávia Amanda Pedroso de Morais, Renato Sonchini Gonçalves, Bruno Henrique Vilsinski, Danielle Lazarin-Bidóia, Rodolfo Bento Balbinot, Tayana Mazin Tsubone, Kellen Brunaldi, Celso Vatatu Nakamura, Noboru Hioka, Wilker Caetano

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Diverse Therapeutic Potentials of Hypericin: An In-Depth Review.Current topics in medicinal chemistry · 2025
    Review
  4. Article
  5. Energy Metabolism Enhance Perylenequinone Biosynthesis inInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Flávia Amanda Pedroso de MoraisChemistry Department, Universidade Estadual de Maringá, 87020-900, Maringá, Paraná, Brazil. flaviaapmorais@hotmail.com.
Renato Sonchini GonçalvesChemistry Department, Universidade Estadual de Maringá, 87020-900, Maringá, Paraná, Brazil.
Bruno Henrique VilsinskiChemistry Department, Universidade Estadual de Maringá, 87020-900, Maringá, Paraná, Brazil.
Danielle Lazarin-BidóiaUniversidade Estadual de Maringá, Technological Innovation Laboratory in the Pharmaceuticals and Cosmetics Development, Department of Health Sciences, 87020-900, Maringá, Paraná, Brazil.
Rodolfo Bento BalbinotUniversidade Estadual de Maringá, Technological Innovation Laboratory in the Pharmaceuticals and Cosmetics Development, Department of Health Sciences, 87020-900, Maringá, Paraná, Brazil.
Tayana Mazin TsuboneUniversidade Federal de Uberlandia, Institute of Chemistry, 38400-902, Minas, Gerais, Brazil.
Kellen BrunaldiPhysiological Sciences Department, Universidade Estadual de Maringá, 87020-900, Maringá, Paraná, Brazil.
Celso Vatatu NakamuraUniversidade Estadual de Maringá, Technological Innovation Laboratory in the Pharmaceuticals and Cosmetics Development, Department of Health Sciences, 87020-900, Maringá, Paraná, Brazil.
Noboru HiokaChemistry Department, Universidade Estadual de Maringá, 87020-900, Maringá, Paraná, Brazil.
Wilker CaetanoChemistry Department, Universidade Estadual de Maringá, 87020-900, Maringá, Paraná, Brazil.
Universidade Estadual de Maringá · BRUniversidade Federal de Uberlândia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypericin (Hyp) is considered a promising photosensitizer for Photodynamic Therapy (PDT), due to its high hydrophobicity, affinity for cell membranes, low toxicity and high photooxidation activity. In this study, Hyp photophysical properties and photodynamic activity against melanoma B16-F10 cells were optimized using DPPC liposomes (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) as a drug delivery system. This nanoparticle is used as a cell membrane biomimetic model and solubilizes hydrophobic drugs. Hyp oxygen singlet lifetime (τ) in DPPC was approximately two-fold larger than that in P-123 micelles (Pluronic™ surfactants), reflecting a more hydrophobic environment provided by the DPPC liposome. On the other hand, singlet oxygen quantum yield values (Φ

Indexed as

Photochemotherapy1,2-DipalmitoylphosphatidylcholineAnthracenesAntineoplastic AgentsCell ProliferationDrug CompoundingDrug Screening Assays, AntitumorDrug StabilityHumansHypericumLiposomesMelanomaMolecular StructurePerylenePhotosensitizing AgentsTumor Cells, Cultured1,2-DipalmitoylphosphatidylcholineAnthracenesAntineoplastic Agentscolfosceril palmitatehypericinLiposomesPerylenePhotosensitizing Agents

Identifiers

PMID32248218
OpenAlexW3013112472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.